scispace - formally typeset
M

Melissa Crenshaw

Researcher at Johns Hopkins University

Publications -  6
Citations -  256

Melissa Crenshaw is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Internal medicine & Channelopathy. The author has an hindex of 2, co-authored 2 publications receiving 187 citations.

Papers
More filters
Journal ArticleDOI

High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phenotype Correlation.

Kitiwan Rojnueangnit, +73 more
- 01 Nov 2015 - 
TL;DR: 136 individuals with a distinct phenotype carrying one of five different NF1 missense mutations affecting p.Arg1809 affect 1.23% of unrelated NF1 probands in the UAB cohort, therefore this specific NF1 genotype–phenotype correlation will affect counseling and management of a significant number of patients.
Journal ArticleDOI

Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848

Magdalena Koczkowska, +74 more
TL;DR: The results demonstrate that a genotype-phenotype correlation at the NF1 region 844–848 exists and will be valuable in the management and genetic counseling of a significant number of individuals.
Journal ArticleDOI

Hypotonic infant with PURA syndrome-related channelopathy successfully treated with pyridostigmine

TL;DR: In this paper , the authors describe the hospital course, diagnostic evaluations as well as neurologic and neuromuscular follow up of an infant diagnosed with PURA syndrome based on a pathogenic deletion at c.697_699 (phe233del) of the PURA gene identified on whole exome sequencing.
Journal ArticleDOI

Corrigendum to ‘Hypotonic Infant with PURA Syndrome-related Channelopathy Successfully Treated with Pyridostigmine’ Neuromuscular Disorders Volume 32, Issue 2, February 2022, Pages 166-169

TL;DR: Iyadurai et al. as mentioned in this paper treated a hypotonic infant with PURA syndrome-related channelopathy successfully treated with pyridostigmine, which can be divided into central and peripheral etiologies.
Journal ArticleDOI

Reader Response: PURA syndrome: neuromuscular junction manifestations with potential therapeutic implications

TL;DR: In this paper , a PURA syndrome patient who benefited from treatment with pyridostigmine was reported to have improved motor performance with the use of salbutamol.